Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03781115Phase 1Recruiting

Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia

Role: collaborator

NCT01923701Not ApplicableCompleted

Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk

Role: collaborator

NCT01551979Not ApplicableCompleted

Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia

Role: collaborator

All 3 trials loaded